Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
747,168
-
Shares change
-
+1,049
-
Total reported value, excl. options
-
$4,127,000
-
Value change
-
+$1,517
-
Number of buys
-
3
-
Number of sells
-
-4
-
Price
-
$5.53
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q1 2017
16 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q1 2017.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 747,168 shares
.
Largest 10 shareholders include HEARTLAND ADVISORS INC (225,000 shares), HealthInvest Partners AB (168,323 shares), PERRITT CAPITAL MANAGEMENT INC (123,514 shares), RENAISSANCE TECHNOLOGIES LLC (77,100 shares), SHUFRO ROSE & CO LLC (44,191 shares), VANGUARD GROUP INC (34,108 shares), Essex Financial Services, Inc. (23,776 shares), WELLS FARGO & COMPANY/MN (23,001 shares), Minerva Advisors LLC (14,559 shares), and MORGAN STANLEY (7,340 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.